- Messages
- 13
Since the two retractions came out concerning XMRV, do patients that have paid for XMRV testing feel that Vip Dx has some sort of obligation to them to refund the fee on this test?
Isn't the WPI a different company than VIP dx?
GG
They obviously sincerely believed in their test and were honest about it not having offical approval
I'm breaking my PR purdah only briefly and I will not reply to comments. Anyone with questions should use the eamil at:http://cfsmirror.blogspot.com/
There have been a number of inaccuracies posted in this thread and the discussion has also lacked some pertinent information:
The WPI is not owned by the Whittemore family, WPI is registered with the IRS as a non profit corporation operating as a publicly supported trust, which means the WPI has no beneficial or controlling owners.
VIPdx, which is a private company has been owned solely by Harvey Whittmore for a number of years, so it is not precisely accurate to say that it is owned by the Whittemores and in terms of direct conflict of interest, none could be implied on the part of the WPI board.
The lack of breadth of the WPI board however, - with only two voting members listed in 2009 (Annette Whittemore and Michael Hillerby ) - could be considered a source of inadequate separation between the Whittemore family interests and the WPI . Not only are Harvey and Annette Whittemore spousally related, but Hillerby is a business colleague of Harvey Whittemore. It may be of further concern that the now listed vice president of WPI is Carli West Kinne who has a long established business relationship with Harvey Whittemore , including at Redlabs/VIPdx and who has also provided professional services to the Whittemore family. These relationships do not in themselves indicate wrong doing but do go to a question of demonstration of avoidance of any appearance of conflict of interest, that is considered good practice in non profit administration.
The proposition that the VIPdx tests were experimental and therefore VIPdx is void of obligation under contract law is not sustainable, because although the XMRV test was not FDA approved, to have the protection of experiment the tests would have to have been provided under approval from a relevant institutional review board, and no such IRB was ever acknowledged. The VIPdx XMRV tests were provided under purely commercial contract law, whatever those buying the tests may have thought. The operational law would have been that of the United States and the State of Nevada, any claim would have to be contingent on prescription given by the relevant legal authorities. Caveat emptor would likely apply, and only be void where misrepresentation could be shown. UK (and likely other European) based purchasers of the test could have sustainable cases against their commissioning doctor for the doctors failure to alert their patient to the unvalidated status of the test.
VIPdx is reported to have paid a licening fee to WPI and this appears to have provided a sum of $226,652 for the WPI in 2010 having been processed via WP Biotechnologies, in that context around 20% of the fees paid to VIP-dx for XMRV tests (based on WPIs own statements about the number tests supplied) may have contributed to supporting the WPI. Whether those who viewed the test purchase as a donation to WPI consider that an appropriate dispersement of income is clearly a personal judgement
Prior to the opening of the Center for Molecular Medicine building the WPI did not have facilities capable of processing tests on a commercial scale, so all VIPdx tests would have been carried out at the VIPdx lab located at a different part of the University of Nevada Reno campus. With the opening of the CMM building, the WPI was able to develop a commercial level of processing and it is this that UNEVX appears to have been created to exploit. VIPdx is still registered as a corporation in Nevada, however if its contracting capacity has been taken over by UNEVX then there there would seem little chance that the business has a active future and any claimsagainst the company would have little chance of being met. There would seem to be little basis to suggest that UNEVX or the WPI would inherit VIPdx liabilities, as they are wholy separate entities from VIPdx
I knew the test was experimental when I signed up. Nobody said otherwise. Also, other CFS experts were advising that it's too soon and probably not money well spent. So it's not as if I didn't have different points of view.
Also, I donated several hundred of dollars to WPI, and for all I know it went to a wild goose chase. But such is life. I was rolling the dice and I knew it. And at the time, they were the only game in town. I thought it was better make an investment, than sit back and wait for the world to change.
Floydguy,
There are many patients in the UK who are supportive of the retroviral research and very grateful to the USA researchers.
Just sorry that we don't make that more clear.
Please don't throw us all in the same boat at IVI.
Internet forums can be joined by people with a wide range of diseases, ideas, problems, solutions and it's important to remember that anyone can post here.
Thank goodness for the brave USA researchers and patients who continue to investigate, fundraise and campaign for all of us.